Astraea
Product & Competitive Intelligence
Automates clinical-trial biometrics into FDA-ready outputs.
Company Overview
Competitors
ICON WorkBench:
Large CRO-backed biometrics automation with deep services reach; Astraea is earlier and more software-native.
Saama Biometrics:
Clinical analytics incumbent automating SDTM, ADaM, and TLF workflows; Astraea competes on agent-first execution.
Clymb Clinical TFL Designer:
Focused on TFL design and clinical reporting templates; Astraea is aiming for a wider source-to-submission workflow.
Astraea
's Moat:
No durable moat yet; the path is workflow switching costs around sponsor-specific CDISC mappings, validation history, and audit trails.
How They're Leveraging AI
Simulation
Simulation support appears to test sample-size and adaptive-design choices before study plans harden into SAPs and reporting work.
Document Understanding
AI-assisted evidence extraction links protocol, SAP, CSR, literature, and safety-document claims back to source text for biometrics review.
Agentic Workflow Automation
Schema-constrained agents turn protocols, SAPs, and raw trial data into SDTM, ADaM, TFLs, Define-XML, and aCRF outputs.
AI Use Overview:
Astraea appears to use schema-constrained LLM agents over clinical docs and datasets, then checks outputs with CDISC rules and Pinnacle 21-style validation.
